Study of CAR-BCMA, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA in Subjects With Multiple Myeloma
NCT05243212
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
75
Enrollment
OTHER_GOV
Sponsor class
Conditions
Multiple Myeloma
Relapse Multiple Myeloma
Interventions
BIOLOGICAL:
CAR-BCMA
Sponsor
Sheba Medical Center